Bladder Cancer is an international multidisciplinary journal aiming to facilitate progress in understanding the epidemiology, etiology, molecular genetics, pathogenesis, pathobiology and pharmacology of tumors of the bladder and upper urinary tract with the objective of improving diagnosis, treatment and survivorship in patients. The journal is directed primarily at researchers and clinicians working on these areas, with some content aimed at patients/patient advocates with these conditions. With this objective in mind, the journal publishes original research reports, systematic and regular reviews, short communications, and letters-to-the-editor in basic science, translational research and clinical medicine. The journal is committed to the highest ethical standards and best practices, and prospective authors are encouraged to consult the relevant author instructions and policies on the website at the time of submission as these are updated regularly to reflect changing guidelines.
The journal features a first class Editorial Board and provides rigorous peer review and rapid online publication; see full list of Editorial Board members here.
For subscription information, click here.
ISSN (p): 2352-3727
ISSN (e): 2352-3735
Bladder Cancer's targeted audience is comprised of basic science researchers and clinicians in the areas of bladder cancer and related disorders.
Web of Science: Current Contents®/Life Sciences
Web of Science: Science Citation Index-Expanded (SciSearch®)
IOS Press serves the information needs of scientific and medical communities worldwide. IOS Press publishes more than 90 international journals and approximately 65 book titles each year on subjects ranging from computer sciences and mathematics to medicine and natural sciences.
Headquartered in Amsterdam with satellite offices in the USA, Germany and China, IOS Press continues its rapid growth, embracing new technologies for the timely dissemination of information.
All journals are available in print and electronic format.